Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Asking your healthcare provider: If your insurance denies Ozempic, try seeing if your physician can help, Dr
Highlights: New genetic study links GLP-1 receptor activation to better mental well-being Researchers found lower genetic odds of depression and bipolar disorder Experts say the findings are promising but not yet ready for clinical use medications targeting the glucagon-like peptide-1 (GLP-1) receptor, better known as GLP-1 drugs, may do more than help people lose weight or control diabetes
While weight loss certainly drives some reductions in inflammatory markers, GLP-1 medicines appear to do far more
Other common side effects include: Hypoglycaemia (especially when used with insulin or sulfonylureas) Fatigue and dizziness Headache Injection site reactions (pain, redness, itching) Gallbladder problems including gallstones Serious but rare adverse effects include pancreatitis, diabetic retinopathy complications (particularly in patients with pre-existing retinopathy when glycaemic control improves rapidly), and potential thyroid C-cell tumours (observed in rodent studies, though human relevance remains uncertain)
However, through the $10 billion acquisition of clinical-stage biotech company Metsera in November 2025, Pfizer secured a next-generation obesity pipeline after an aggressive bidding war with Novo
Here are some other factors that will influence the extent of your results: Your activity levels and the type of activity you participate in Your weight at the beginning of your treatment plan Your resting metabolic rate Your diet In general, patients with much higher BMIs (class II and class III obesity) may begin to shed pounds within just the first couple of weeks
